As of 2026-07-19, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 71.71 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -60.7%.
The range of the Relative Valuation is 63.96 - 85.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.9x - 27.9x | 25.7x |
| Forward P/E multiples | 24.6x - 27.6x | 24.8x |
| Fair Price | 63.96 - 85.69 | 71.71 |
| Upside | -65.0% - -53.0% | -60.7% |
| Date | P/E |